These results suggest that ATF6 supports Wnt signaling in colorectal cancer independently of XBP1s, inviting future consideration that nATF6 may directly act on Wnt pathway target genes or potentially as a cofactor to β-catenin. The gene discussed is ATF6; the disease is colorectal cancer.